The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
October 30th 2024
A decade after bariatric surgery, most teens maintained weight loss and reduced obesity-related conditions such as type 2 diabetes and hypertension.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Metabolic Syndrome and Nut Consumption Linked in Adolescents
Due to allergy concerns and changing dietary habits, children (particularly adolescents) are consuming fewer nuts. Some researchers are concerned that the lack of this key food could contribute to other health issues later in life.
Weighing the Risks of Quitting Smoking and Obesity
One of the major concerns of people considering quitting smoking is whether they will gain weight. A new study has shown that may not need to be a concern and that the overall benefits to their health can outweigh the risks.
Improving the Safety of Diabetes Medications
As more diabetes drugs hit the market there are natural safety questions that come with these prescriptions. In recent years the US Food and Drug Administration has worked to increase the steps taken to ensure the safety of these drugs.
Bariatric Surgery Reduces Diabetes-Associated Vascular Disease in Obese Patients
March 6th 2015Bariatric surgery has been shown to reduce the long-term risk of diabetes-associated vascular disease in obese patients. According to study results presented at ENDO 2015, bariatric surgery reduced the risk of developing macrovascular events by 20% and reduced the risk of microvascular events by 50%.
Liraglutide Associated with Improved Glycemic Control in Overweight Patients with Prediabetes
March 6th 2015In overweight and obese individuals without diabetes, liraglutide 3.0 mg as an adjunct to diet and exercise was associated with greater reductions in fasting and postprandial glucose compared with diet and exercise alone.
Comparing Two Types of Obesity Surgeries: Which Is Better?
March 6th 2015Study results show that patients who underwent Roux-en-Y gastric bypass surgery experienced greater and more rapid weight loss at 12- and 24 months post-surgery compared to patients who received the sleeve gastrectomy procedure. GB patients also experienced a larger decrease in hemoglobin within the first two months post-surgery and a sustained decrease in creatinine.
Hazard Report: New Primer on Deadly Dirty Scopes
Deaths and infections traced to duodenoscopes contaminated with carbapenem-resistant enterobacteriaceae infections are on the rise. The ECRI Institute, a nonprofit research and testing lab, today put out a "high priority hazard report" on procedures for cleaning the devices. It isn't easy.
FDA Warning: Testosterone Can Kill
Manufacturers of prescription testosterone products must change their drug labels to include a warning about increased risk of heart attacks and strokes. The labeling change, announced today by the US Food and Drug Administration (FDA) addresses the use of testosterone by men whose decreased level of the hormone is due to aging.
Subspecialty Care and the Endocrinologist: Let's Get Virtual
March 3rd 2015Researchers from the Division of Endocrinology and Metabolism at the University of California, San Francisco analyzed the impact of virtual consultations on the spectrum and volume of endocrine consults. They measured access to endocrine care and downstream health care utilization. Their results indicate that virtual consultation offers many advantages for endocrinologists.
Mobilizing Immunotherapy for Type 1 Diabetes: On the Horizon
March 3rd 2015Type 1 diabetes mellitus is an autoimmune disease in which the body destroys all or part of its own roughly 1 billion β cells and cannot regenerate these critical endocrine components. Researchers have turned their attention to immunotherapies for treatment, postulating that targeting the immune system might restore β-cell function. It appears that combination therapies may be needed since clinical trial results have not met expectations based on animal studies.
The Use of Incretin-Based Therapy in Asian Patients with Diabetes
February 25th 2015Among the approximately 382 million people who have type 2 diabetes (T2DM) worldwide, approximately 20% live in South-East Asia and 65.1 million live in India. Asian populations are racially, demographically, culturally and socioeconomically heterogeneous. Researchers have identified unique trends in Asians diagnosed with T2DM.
Lipodystrophy: What HAART Has Taught Us
February 25th 2015The most common causes of lipodystrophy are insulin injection, antiretroviral drugs, and hereditary disorders. Some patients with insulin-related lipodystrophy also develop metabolic dysfunction, including insulin resistance, elevated free fatty acids level, abnormal adipocytokine secretion, and ectopic fat deposition.